143 related articles for article (PubMed ID: 37030103)
1. Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer.
Kumar S; Das A
Comput Biol Chem; 2023 Jun; 104():107867. PubMed ID: 37030103
[TBL] [Abstract][Full Text] [Related]
2. Application of explainable artificial intelligence in the identification of Squamous Cell Carcinoma biomarkers.
Meena J; Hasija Y
Comput Biol Med; 2022 Jul; 146():105505. PubMed ID: 35477047
[TBL] [Abstract][Full Text] [Related]
3. Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
Yagin FH; Cicek İB; Alkhateeb A; Yagin B; Colak C; Azzeh M; Akbulut S
Comput Biol Med; 2023 Mar; 154():106619. PubMed ID: 36738712
[TBL] [Abstract][Full Text] [Related]
4. Explainable machine learning for breast cancer diagnosis from mammography and ultrasound images: a systematic review.
Gurmessa DK; Jimma W
BMJ Health Care Inform; 2024 Feb; 31(1):. PubMed ID: 38307616
[TBL] [Abstract][Full Text] [Related]
5. Explainability and Transparency of Classifiers for Air-Handling Unit Faults Using Explainable Artificial Intelligence (XAI).
Meas M; Machlev R; Kose A; Tepljakov A; Loo L; Levron Y; Petlenkov E; Belikov J
Sensors (Basel); 2022 Aug; 22(17):. PubMed ID: 36080795
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of ensemble learning to predict water quality using explainable artificial intelligence.
Park J; Lee WH; Kim KT; Park CY; Lee S; Heo TY
Sci Total Environ; 2022 Aug; 832():155070. PubMed ID: 35398119
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer detection using artificial intelligence techniques: A systematic literature review.
Nassif AB; Talib MA; Nasir Q; Afadar Y; Elgendy O
Artif Intell Med; 2022 May; 127():102276. PubMed ID: 35430037
[TBL] [Abstract][Full Text] [Related]
8. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
9. Explainable discovery of disease biomarkers: The case of ovarian cancer to illustrate the best practice in machine learning and Shapley analysis.
Huang W; Suominen H; Liu T; Rice G; Salomon C; Barnard AS
J Biomed Inform; 2023 May; 141():104365. PubMed ID: 37062419
[TBL] [Abstract][Full Text] [Related]
10. eXplainable Artificial Intelligence (XAI) in aging clock models.
Kalyakulina A; Yusipov I; Moskalev A; Franceschi C; Ivanchenko M
Ageing Res Rev; 2024 Jan; 93():102144. PubMed ID: 38030090
[TBL] [Abstract][Full Text] [Related]
11. A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology.
Ciaramella A; Di Nardo E; Terracciano D; Conte L; Febbraio F; Cimmino A
BMC Bioinformatics; 2023 Mar; 23(Suppl 6):569. PubMed ID: 36879192
[TBL] [Abstract][Full Text] [Related]
12. A Hybrid Algorithm of ML and XAI to Prevent Breast Cancer: A Strategy to Support Decision Making.
Silva-Aravena F; Núñez Delafuente H; Gutiérrez-Bahamondes JH; Morales J
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173910
[TBL] [Abstract][Full Text] [Related]
13. Explainable artificial intelligence for pharmacovigilance: What features are important when predicting adverse outcomes?
Ward IR; Wang L; Lu J; Bennamoun M; Dwivedi G; Sanfilippo FM
Comput Methods Programs Biomed; 2021 Nov; 212():106415. PubMed ID: 34715520
[TBL] [Abstract][Full Text] [Related]
14. Applications of Explainable Artificial Intelligence in Diagnosis and Surgery.
Zhang Y; Weng Y; Lund J
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204328
[TBL] [Abstract][Full Text] [Related]
15. Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer.
Chakraborty D; Ivan C; Amero P; Khan M; Rodriguez-Aguayo C; Başağaoğlu H; Lopez-Berestein G
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298668
[TBL] [Abstract][Full Text] [Related]
16. Application of explainable artificial intelligence for healthcare: A systematic review of the last decade (2011-2022).
Loh HW; Ooi CP; Seoni S; Barua PD; Molinari F; Acharya UR
Comput Methods Programs Biomed; 2022 Nov; 226():107161. PubMed ID: 36228495
[TBL] [Abstract][Full Text] [Related]
17. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract][Full Text] [Related]
18. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.
Kırboğa KK; Küçüksille EU; Naldan ME; Işık M; Gülcü O; Aksakal E
Comput Methods Programs Biomed; 2023 May; 233():107492. PubMed ID: 36965300
[TBL] [Abstract][Full Text] [Related]
19. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
Sherafatian M
Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
